US7354417B1 - Methods and apparatus for measuring the volume of fluid in the peritoneal cavity - Google Patents

Methods and apparatus for measuring the volume of fluid in the peritoneal cavity Download PDF

Info

Publication number
US7354417B1
US7354417B1 US10/089,831 US8983100A US7354417B1 US 7354417 B1 US7354417 B1 US 7354417B1 US 8983100 A US8983100 A US 8983100A US 7354417 B1 US7354417 B1 US 7354417B1
Authority
US
United States
Prior art keywords
subject
current
peritoneal cavity
fluid
electrodes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime, expires
Application number
US10/089,831
Inventor
Nathan W. Levin
Daniel Schneditz
Fansan Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/089,831 priority Critical patent/US7354417B1/en
Priority claimed from PCT/US2000/027048 external-priority patent/WO2001024847A1/en
Application granted granted Critical
Publication of US7354417B1 publication Critical patent/US7354417B1/en
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4869Determining body composition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/282Operational modes
    • A61M1/284Continuous flow peritoneal dialysis [CFPD]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0531Measuring skin impedance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813Specially adapted to be attached to a specific body part
    • A61B5/6823Trunk, e.g., chest, back, abdomen, hip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683Means for maintaining contact with the body
    • A61B5/6831Straps, bands or harnesses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation

Definitions

  • This invention relates to peritoneal dialysis and, in particular, to the measurement of the volume of fluid in the peritoneal cavity during such dialysis.
  • Peritoneal dialysis involves introducing dialysis fluid into the peritoneal cavity of a subject.
  • the dialysis fluid is introduced and removed batch wise (i.e., in cycles) to facilitate control of the dialysis process, i.e., to allow measurements to be performed on the dialysate as the procedure progresses, e.g., measurements of the volume of the dialysate introduced and removed from the subject.
  • PET peritoneal equilibration test
  • the invention provides a method for determining the volume of fluid in the peritoneal cavity of a subject comprising:
  • V ( K P / ⁇ ) ⁇ ( L P 2 /R ) Eq. (1)
  • K P is a subject-specific calibration constant
  • is the conductivity of the fluid in the peritoneal cavity
  • L P is the distance between the loin plane and the buttock plane
  • K P is determined by:
  • K P is determined by:
  • K P ( ⁇ C ) ⁇ ( V C /L P 2 ) ⁇ ( R B R A )/( R A ⁇ R B ) Eq. (3)
  • the invention provides a method of controlling a peritoneal dialysis procedure comprising:
  • step (B) determining the volume of fluid in the peritoneal cavity while step (A) is being performed by a bioimpedance measurement directed at the peritoneal cavity;
  • step (C) controlling step (A) based on the volume of fluid in the peritoneal cavity determined in step (B).
  • step (B) is performed by using the above-described bioimpedance method for determining the volume of fluid in the peritoneal cavity of the subject.
  • the invention provides apparatus for practicing the above methods, including suitably programmed computers, e.g., personal computers, for performing the computation aspects of the invention.
  • loin means the region of a subject's body at approximately the level of the bottom of the rib cage, plus or minus 5-10 centimeters.
  • the loin region includes the subject's front, back, and sides at this level.
  • buttock means the rounded part of the back of the hips and the uppermost part of the thighs.
  • upper and lower are used in an electrical sense relative to the subject's peritoneal cavity irrespective of the actual orientation of the subject.
  • the passage of current from the upper electrodes to the lower electrodes causes at least some current to flow through the subject's peritoneal cavity from its thoracic end to its pelvic end irrespective of whether the subject is standing, sitting, or laying down.
  • the gravity-based definitions of “upper” and “lower” and the electrical-based definitions are the same.
  • FIG. 1 is a schematic diagram illustrating the meaning of the terms “loin” and “buttock” as used in the specification and claims.
  • FIG. 2 is a schematic diagram illustrating suitable locations for measuring electrodes M LL , M RL , M LB , and M RB , which focus (direct) a bioimpedance measurement towards the subject's peritoneal cavity (PC).
  • PC peritoneal cavity
  • FIG. 3 is a schematic diagram of suitable equipment that can be used in the practice of the invention to apply current and to measure the resulting voltages on the surface of the subject's body.
  • FIG. 4 illustrates use of the techniques of the invention to monitor changes in the volume of the peritoneal cavity, including the accumulation of ultrafiltrate, during a batch wise peritoneal dialysis procedure.
  • FIG. 5 shows the correlation between measured values of the ultrafiltration volume (UFV) accumulated in the peritoneal cavity (horizontal axis) and values determined using the bioimpedance analysis (BIA) techniques of the invention (vertical axis).
  • UUV ultrafiltration volume
  • BIOA bioimpedance analysis
  • FIG. 6 is a schematic diagram illustrating common supports that can be used for (1) the upper current-providing electrodes and the loin measuring electrodes ( FIG. 6A ) and (2) the lower current-providing electrodes and buttock measuring electrodes ( FIGS. 6B and 6C ).
  • the present invention relates to the measurement of the volume of fluid in the peritoneal cavity by applying current to the body of a human or an animal and recording voltages at selected portions of the body chosen to reflect the anatomical boundaries of the peritoneal cavity.
  • FIG. 2 shows one example of the location of current-providing electrodes (I RU , I LU , I RL and I LL ) and measuring electrodes (M LL , M RL , M LB , and M RB ) which achieve this result, where the peritoneal cavity (PC) is schematically shown as a shaded cylinder within the subject's torso.
  • PC peritoneal cavity
  • the current can be applied and the voltages measured using various commercially available equipment for performing bioimpedance measurements, such as, the bioimpedance analysis devices sold by Xitron Technologies, Inc., San Diego, Calif.
  • the use of alternating current is preferred, although direct current can be used if desired.
  • the alternating current preferably has a frequency between about 5 kilohertz and about 500 kilohertz, a frequency of about 5 kilohertz being most preferred.
  • Bioimpedance analysis devices typically output both resistance and reactance values, i.e., the equipment outputs complex impedances.
  • the reactance values and/or the magnitudes of the complex impedances can be used in the practice of the invention.
  • the real part of the impedance i.e., the resistance value
  • the resistance value is less sensitive to noise interference and thus its use is preferred.
  • the “R” values discussed above and set forth in the claims can be resistance values, reactance values, values for the magnitude of the complex impedance, or combinations thereof, as desired.
  • apparatus of the type shown in FIG. 3 is used to apply current to the current-providing electrodes and to measure sequentially the voltages at the measuring electrodes on the right and left sides of the body.
  • the apparatus includes connectors 1 , 2 , 3 , and 4 which serve to interface bioimpedance analysis device 5 to the eight electrodes used in the practice of the invention.
  • more than eight electrodes can be used in the practice of the invention if desired, e.g., more measuring electrodes and/or more current-providing electrodes can be used. In the limit, ring or band electrodes can be used. Calculation of the average resistance R in equation (1), as well as R A and R B in equations (2) and (3), will vary when electrode configurations having more than eight electrodes and/or one or more ring electrodes are used. For example, if more than two pairs of measuring electrodes are used, the average will be over all of the vertically aligned electrode pairs.
  • ring electrodes used for both the loin and buttock measuring electrodes the averaging process is performed by the electrodes themselves, so that all that is needed is a determination of the voltage between the ring electrodes while current I is applied.
  • the approaches for other combinations e.g., a ring electrode for the loin measuring electrode and two or more discrete electrodes for the buttock measuring electrodes) will be evident to workers skilled in the art from the disclosure herein.
  • Connectors 1 and 2 in FIG. 3 serve as switches to provide left and right side voltage measurements. Specifically, when these connectors are in their upper positions in FIG. 3 , left side voltage differences are measured, and when they are in their lower positions, right side voltage differences are measured. Connectors 3 and 4 carry current from the bioimpedance analysis device to the upper and lower current-providing electrodes, respectively.
  • the output of the bioimpedance analysis device e.g., the difference in voltage between the left measuring electrodes when connectors 1 and 2 are in their upper positions
  • Interface 7 and/or computer 6 can perform processing, e.g., digital signal processing, on the output from bioimpedance analysis device, e.g., low pass filtering to remove noise from the voltage signal.
  • processing e.g., digital signal processing
  • the amount of fluid introduced or removed from the subject's peritoneal cavity during the calibration procedure is inputted to the personal computer from the dialysis equipment through A/D converter 8 .
  • the personal computer preferably includes a keyboard 9 for entry of commands from a user and a display 10 and printer 11 for outputting data indicative of the volume of fluid in the subject's peritoneal cavity.
  • the system preferably includes a control module 12 which provides feedback to the dialysis equipment during, for example, a continuous peritoneal dialysis procedure in order to control, for example, the ultrafiltration rate.
  • the current-providing electrodes need to be outboard of the measuring electrodes so as to generate a readily measurable voltage difference between the measuring electrodes.
  • “outboard” means that relative to the peritoneal cavity, the current-providing electrodes are more distal than the measuring electrodes.
  • the current-providing electrodes and the measuring electrodes are grouped together for application to the subject's body using a common support.
  • grouping facilitates use of the equipment in, for example, an in-home environment.
  • the upper current-providing electrodes and the loin measuring electrodes can be carried by a single belt which is applied to the subject just below the rib cage.
  • the lower current-providing electrodes and the buttock measuring electrodes can be carried by a single belt or an elastic garment which is applied to or worn by the subject.
  • two belts can be used for the lower current-providing electrodes and buttock measuring electrodes, said belts being applied high on the subject's upper thigh, preferably extending up into the buttock region.
  • the current-providing and measuring electrodes can be applied using adhesive patches, e.g., two patches for the upper current-providing electrodes and loin measuring electrodes and two patches for the lower current-providing electrodes and buttock measuring electrodes. With such supports, the current-providing electrodes are preferably at least about 5 centimeters outboard of the measuring electrodes.
  • FIG. 6A illustrates the use of a single common support for upper current-providing electrodes (I RU and I LU ) and loin measuring electrodes (M RL and M LL ). Electrodes I RU and I LU are used to inject current from the bioimpedance analysis device to the right side and left sides of the body, respectively. Electrodes M RL and M LL are used to measure voltage from the right and left sides, respectively. Electrodes I RU , I LU , M RL , and M LL are connected to the bioimpedance analysis device by lead 23 .
  • the vertical distance between the two rows of electrodes is preferably about 5 cm and the width of the support is preferably about 8 cm.
  • VELCRO fasteners 20 , 22 are used to close the support after it is applied to the patient's loins. Such fasteners allow the device to be used with patients having varying loin circumferences. Other types of fasteners can, of course, be used in the practice of the invention if desired.
  • FIGS. 6B and 6C illustrate the use of two common supports for the lower current-providing electrodes (I RL and I LL ) and buttock measuring electrodes (M RB and M LB ). These supports are placed on the patient's right and left buttocks respectively using VELCRO fasteners 20 , 22 . The electrodes of the supports have a similar spacing to those of FIG. 6A . Likewise, the supports have a similar width. The current-providing and buttock measuring electrodes are connected to the bioimpedance analysis device by leads 24 and 25 .
  • Both the current-providing and the measuring electrodes of FIGS. 6A , 6 B, and 6 C can be Ag/AgCl electrodes or can be composed of a conductive rubber which is affixed to the support.
  • the electrode system of FIG. 6 has the advantage that four injecting current electrodes and four measuring electrodes are integrated on three bands so that the patient does not need to place eight separate electrodes on his or her body. Further, the use of a common support leads to improved measurement accuracy because the electrodes can be more readily placed at their desired locations and are more likely to achieve a stable connection with the patient's skin.
  • the current-providing electrodes are significantly further outboard from the measuring electrodes, e.g., the current-providing electrodes can be placed on the subject's hands and feet as illustrated in FIG. 2 .
  • the upper and lower current-providing electrodes are on opposite sides of the subject's frontal plane so that current passes across that plane, although current-providing electrodes (and measuring electrodes) can be located on the same side of the frontal plane, e.g., on the subject's anterior surface, if desired.
  • locating the loin measuring electrodes substantially above or below the level of the diaphragm results in low sensitivity to changes in the peritoneal fluid volume.
  • locating the buttock measuring electrodes either too high or too low reduces the ability to detect the entire volume of fluid in the peritoneal cavity, especially when the subject is sitting and fluid collects at the bottom of the peritoneal cavity.
  • peritoneal fluid varies between subjects, it is important to calibrate the voltages obtained from the measuring electrodes using a measured volume of fluid which is either inserted into the peritoneal cavity or removed therefrom. Such calibration also helps account for variations in body composition and anatomical configuration between different subjects, as well as variations in electrode placement and connection to the skin.
  • the amount of fluid used for calibration is preferably at least one liter.
  • Equations (1) to (3) include the effects of changes in the conductivity ( ⁇ ) of the fluid in the peritoneal cavity.
  • a constant value for the conductivity can be used during calibration and measurement, e.g., a value of 21.3 mS/cm.
  • the effects of changes in conductivity can be included in the calibration procedure through measurement of the conductivity of the measured volumes of fluid provided to or removed from the peritoneal cavity during calibration.
  • the effects of changes in conductivity during a peritoneal dialysis procedure can be taken into account by measuring the conductivity of the dialysate removed from the subject.
  • the above techniques for measuring the volume of fluid in the peritoneal cavity are used to control a continuous peritoneal dialysis procedure, e.g., an overnight procedure whose duration is at least three hours and preferably at least six hours.
  • measurements of the volume of fluid in the peritoneal cavity are made periodically or, preferably, continuously, and used to control such variables as the rate of inflow of dialysis fluid to the subject, the rate of outflow of dialysis fluid from the subject, and/or the composition of the dialysis fluid, e.g., the glucose concentration.
  • the amount of dialysis fluid supplied to the subject and/or the glucose concentration of that fluid can be decreased.
  • the conductivity of the fluid removed from the patient can be measured either periodically or continuously as a further measure of the course of the dialysis procedures and/or to fine tune the measurement of the volume of fluid in the peritoneal cavity, as discussed above.
  • Various types of equipment known in the art for performing peritoneal dialysis, as well as for measuring the conductivity of fluids, can be used in the practice of these embodiments of the invention.
  • two catheters For performing continuous peritoneal dialysis, two catheters, one for supplying dialysis fluid and the other for removing dialysate, can be used, or a single catheter having two lumens, i.e., an inflow lumen and an output lumen, can be employed.
  • fluid volumes in the peritoneal cavity only need to be determined to within about 0.25 liters. Accordingly, in most applications, only a single calibration needs to be performed at the beginning of a dialysis procedure, as is preferred when continuous peritoneal dialysis is performed. Of course, more frequent calibrations can be performed if desired.
  • the mathematical operations described herein can be performed using a variety of computers and software. For example, those operations can be performed using the VISUAL BASIC program of Microsoft's EXCEL software and a personal computer configured to run that program in accordance with the program manufacturer's specifications.
  • the resulting programs can be stored on various storage media for use and/or distribution, e.g., the programs can be stored on removable magnetic discs, non-removable magnetic discs, or optical discs.
  • the overall computer system should include means for inputting data, e.g., interface 7 in FIG. 3 , and means for outputting the results both in electronic and visual form, e.g., display 10 and printer 11 in FIG. 3 .
  • the output can also be stored on a disk drive, tape drive, or the like for further analysis and/or subsequent display.
  • Alternating current (5 kHz, 0.8 mA) was injected from alternate body sides in 1 minute intervals using four current-providing electrodes placed on both hands and feet.
  • Four measuring electrodes were put on both sides of the loins and on the buttocks to measure impedance or, more specifically, resistance.
  • FIG. 2 schematically shows the electrode placement that was used in collecting the data of the examples.
  • the subject was in a sitting body position during the measurement.
  • the weights of drained and filling fluids were measured using an electronic scale.
  • the volume of fluid in the peritoneal cavity was calculated from the average resistance measured on both body sides as described above. The measurements were calibrated through a determination of K P as also described above.
  • Switching between the right and left measurement electrodes was performed using the apparatus of FIG. 3 .
  • a XITRON bioimpedance analysis device was used to apply currents and to measure skin voltages.
  • bioimpedance techniques of the present invention reliably monitor changes in the volume of fluid in the peritoneal cavity of a subject undergoing peritoneal dialysis. It further demonstrates that the techniques of the invention reliably measure the accumulation of ultrafiltrate in the peritoneal cavity.
  • FIG. 4 is a trace of the volume of fluid in the peritoneal cavity calculated using equation (1) above.
  • the technique of the invention accurately measured the various exchanges in peritoneal fluid.
  • the technique detected the 0.35 liter ultrafiltration volume (UFV) which accumulated in the peritoneal cavity during the fourth dwell period which began at about 210 minutes into the experiment.
  • UUV ultrafiltration volume
  • the ultrafiltration volume was defined as the difference between the volume of peritoneal fluid after the dwell period and the volume of dialysis fluid introduced at the beginning of the experiment, i.e., the difference between the final volume after the dwell period and 2 liters.
  • FIG. 5 is a plot of the results of this experiment, where the vertical axis is the ultrafiltration volume determined using equation (1) and the horizontal axis is the measured ultrafiltration volume. As can be seen in this figure, the values calculated in accordance with the technique of the invention are essentially linearly correlated with the measured values.
  • This example illustrates the importance of locating the measuring electrodes in the subject's loin and buttock regions.
  • the normal peritoneal fluid was drained and replaced with dialysis fluid.
  • the average volume of fluid drained was ⁇ 2.15 ⁇ 0.48 liters.
  • the average volume of dialysis fluid introduced into the peritoneal cavity was 2.1 ⁇ 0.2 liters.
  • the change in fluid volume of the peritoneal cavity between the original state and the drained state (the drain volume) and between the drained stated and the filled state (fill volume) was measured using the technique of the invention with measuring electrodes placed on the subject's loins and buttocks. Measurements were also made with the measuring electrodes placed on the subject's hands and feet.
  • the drain and fill volumes measured using the technique of the invention were ⁇ 2.0 ⁇ 0.5 liters and 1.7 ⁇ 0.45 liters, respectively. With the measuring electrodes placed on the hands and feet, the drain and fill volumes were ⁇ 0.27 ⁇ 0.51 liters and 0.14 ⁇ 0.46 liters, respectively. The difference between the two measurement techniques was significant at the P ⁇ 0.001 level. The superiority of the technique of the invention is evident from this data.

Abstract

Methods and apparatus for determining peritoneal cavity fluid volume include four groups of two electrodes applied to a subject's skin. Measuring electrodes (MLL, MRL) are applied to the subject's loins, measuring electrodes (MLB, MRB) are applied to the subject's buttocks, and upper and lower current-providing electrodes (IRU, ILU, IRL, ILL) are applied to the subject's left and right sides distal from the measuring electrodes (MLL, MRL, MLB, MRB). The resistance between left measuring electrodes (MLL, MLB) is measured and the resistance between right measuring electrodes (MRL, MRB) is measured while current is applied between the upper and lower current-providing electrodes. By averaging resistance values, in combination with a calibration procedure, measurements of peritoneal cavity fluid volume are obtained. The measurement techniques can be used in continuous flow peritoneal dialysis to control or adjust dialysis parameters based on peritoneal cavity fluid.

Description

CROSS REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national phase under 35 USC §371 of International Application No. PCT/US00/27048 filed Sep. 29, 2000, which was published in English under PCT Article 21(2) on Apr. 12, 2001 as International Publication No. WO 01/24847. This application claims the benefit under 35 USC §119(e) of U.S. Provisional Application No. 60/157,785 filed Oct. 5, 1999.
FIELD OF THE INVENTION
This invention relates to peritoneal dialysis and, in particular, to the measurement of the volume of fluid in the peritoneal cavity during such dialysis.
BACKGROUND OF THE INVENTION
Peritoneal dialysis involves introducing dialysis fluid into the peritoneal cavity of a subject. Conventionally, the dialysis fluid is introduced and removed batch wise (i.e., in cycles) to facilitate control of the dialysis process, i.e., to allow measurements to be performed on the dialysate as the procedure progresses, e.g., measurements of the volume of the dialysate introduced and removed from the subject.
It has been recognized in the art for some time that continuous flow of dialysate to and from the subject would improve the efficiency of peritoneal dialysis. For example, where a batch wise procedure typically passes 2 liters of dialysate through the peritoneal cavity in an hour, a continuous process will pass 18 liters in the same period of time. This passage of large volumes of dialysate means that substantially greater amounts of uremic toxins can be removed using the continuous approach as compared to the batch wise approach.
The continuous approach, however, runs the risk of a significant accumulation of fluid in the peritoneal cavity through ultrafiltration of the subject's bodily fluids into the dialysate. Alternatively, high levels of fluid can be absorbed into the subject's tissues, which is also potentially dangerous. Prior to the present invention, the only way to address these risks was to periodically stop the process and determine the amount of fluid in the peritoneal cavity by draining the fluid and measuring its volume. This, of course, defeats the goal of having a continuous process and makes the process less acceptable to the subject.
Prior workers in the art have considered using so called whole-body bioimpedance measurements to estimate the volume of fluid in the peritoneal cavity during batch wise peritoneal dialysis. See Rallison et al., “Errors in estimating peritoneal fluid by bioelectrical impedance analysis and total body electrical conductivity,” Journal of the American College of Nutrition, 12:66-72, 1993. These workers concluded that this measurement technique did not provide a reliable measurement of changes in fluid volume in the peritoneal cavity.
Significantly, this prior unsuccessful work did not involve continuous peritoneal dialysis where the need for fluid volume measurement is more critical than in a batch wise setting. In particular, in continuous peritoneal dialysis, one needs at least periodic and, preferably, a continuous measurement of changes in the volume of fluid in the peritoneal cavity to ensure the safety of the subject. Moreover, for the same reason, the measurement needs to be reliable.
SUMMARY OF THE INVENTION
In view of the foregoing, it is an object of the invention to provide improved methods and apparatus for determining the volume of fluid in the peritoneal cavity of a subject, i.e., a human or an animal. It is a further object of the invention to employ such methods and apparatus in a continuous peritoneal dialysis procedure. It is an additional object of the invention to employ such methods and apparatus in connection with tests of peritoneal function in subjects undergoing dialysis, e.g., in conjunction with a peritoneal equilibration test (PET).
To achieve these and other objects, the invention provides a method for determining the volume of fluid in the peritoneal cavity of a subject comprising:
(a) placing measuring electrodes MLL and MRL on the loins of the subject, MLL being placed on the left loin and MRL being placed on the right loin, MLL and MRL defining a loin plane;
(b) placing measuring electrodes MLB and MRB on the buttocks of the subject, MLB being placed on the left buttock and MRB being placed on the right buttock, MLB and MRB defining a buttock plane;
(c) placing upper current-providing electrodes ILU and IRU on the subject, ILU being outboard of measuring electrode MLL and IRU being outboard of measuring electrode MRL;
(d) placing lower current-providing electrodes IRL and ILL on the subject, IRL being outboard of measuring electrode MRB and ILL being outboard of measuring electrode MLB;
(e) connecting upper current-providing electrode ILU to upper current-providing electrode IRU;
(f) connecting lower current-providing electrode ILL to lower current-providing electrode IRL;
(g) applying current I between the connected upper current-providing electrodes and the connected lower current-providing electrodes;
(h) measuring the voltage ΦL between MLL and MLB while current I is applied;
(i) measuring the voltage ΦR between MRL and MRB while current I is applied; and
(j) determining the volume V of fluid in the peritoneal cavity based on the equation:
V=(K P/σ)·(L P 2 /R)  Eq. (1)
where:
(1) KP is a subject-specific calibration constant;
(2) σ is the conductivity of the fluid in the peritoneal cavity;
(3) LP is the distance between the loin plane and the buttock plane; and
(4) R is the average of RL and RR, where
R LL/I, and
R RR/I.
In certain embodiments of the invention, KP is determined by:
(i) performing steps (g), (h), and (i) before the introduction of a predetermined volume VC of dialysis fluid into the subject's peritoneal cavity to obtain ΦLB and ΦRB, said dialysis fluid having a conductivity σC;
(ii) performing steps (g), (h), and (i) after the introduction of a predetermined volume VC of dialysis fluid into the subject's peritoneal cavity to obtain ΦLA and ΦRA; and
(iii) determining KP from the equation:
K P=(σC)·(V C /L P 2)·(R B R A)/(R B −R A)  Eq. (2)
where
R B=(ΦLBRB)/(2I), and
R A=(ΦLARA)/(2I).
In other embodiments, KP is determined by:
(i) introducing dialysis fluid into the subject's peritoneal cavity;
(ii) performing steps (g), (h), and (i) to obtain ΦLB and ΦRB;
(iii) removing fluid from the subject's peritoneal cavity;
(iv) performing steps (g), (h), and (i) to obtain ΦLA and ΦRA; and
(v) determining KP from the equation:
K P=(σC)·(V C /L P 2)·(R B R A)/(R A −R B)  Eq. (3)
where
    • RB=(ΦLBRB)/(2I),
    • RA=(ΦLARA)/(2I), and
    • VC and σC are, respectively, the volume and conductivity of the fluid removed in step (iii).
In accordance with others of its aspects, the invention provides a method of controlling a peritoneal dialysis procedure comprising:
(A) continuously flowing dialysis fluid through a subject's peritoneal cavity, said flowing of dialysis fluid being capable of causing the accumulation of ultrafiltrate from the subject in the peritoneal cavity;
(B) determining the volume of fluid in the peritoneal cavity while step (A) is being performed by a bioimpedance measurement directed at the peritoneal cavity; and
(C) controlling step (A) based on the volume of fluid in the peritoneal cavity determined in step (B).
Preferably, step (B) is performed by using the above-described bioimpedance method for determining the volume of fluid in the peritoneal cavity of the subject.
In accordance with still further of its aspects, the invention provides apparatus for practicing the above methods, including suitably programmed computers, e.g., personal computers, for performing the computation aspects of the invention.
As used herein and illustrated in FIG. 1, the term “loin” means the region of a subject's body at approximately the level of the bottom of the rib cage, plus or minus 5-10 centimeters. The loin region includes the subject's front, back, and sides at this level.
As used herein and illustrated in FIG. 1, the term “buttock” means the rounded part of the back of the hips and the uppermost part of the thighs.
The terms “upper” and “lower” are used in an electrical sense relative to the subject's peritoneal cavity irrespective of the actual orientation of the subject. Thus, the passage of current from the upper electrodes to the lower electrodes causes at least some current to flow through the subject's peritoneal cavity from its thoracic end to its pelvic end irrespective of whether the subject is standing, sitting, or laying down. For a standing subject with his/her arms above his/her head, the gravity-based definitions of “upper” and “lower” and the electrical-based definitions are the same.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic diagram illustrating the meaning of the terms “loin” and “buttock” as used in the specification and claims.
FIG. 2 is a schematic diagram illustrating suitable locations for measuring electrodes MLL, MRL, MLB, and MRB, which focus (direct) a bioimpedance measurement towards the subject's peritoneal cavity (PC).
FIG. 3 is a schematic diagram of suitable equipment that can be used in the practice of the invention to apply current and to measure the resulting voltages on the surface of the subject's body.
FIG. 4 illustrates use of the techniques of the invention to monitor changes in the volume of the peritoneal cavity, including the accumulation of ultrafiltrate, during a batch wise peritoneal dialysis procedure.
FIG. 5 shows the correlation between measured values of the ultrafiltration volume (UFV) accumulated in the peritoneal cavity (horizontal axis) and values determined using the bioimpedance analysis (BIA) techniques of the invention (vertical axis).
FIG. 6 is a schematic diagram illustrating common supports that can be used for (1) the upper current-providing electrodes and the loin measuring electrodes (FIG. 6A) and (2) the lower current-providing electrodes and buttock measuring electrodes (FIGS. 6B and 6C).
The foregoing drawings, which are incorporated in and constitute part of the specification, illustrate various embodiments of the invention, and together with the description, serve to explain the principles of the invention. It is to be understood, of course, that both the drawings and the description are explanatory only and are not restrictive of the invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
As discussed above, the present invention relates to the measurement of the volume of fluid in the peritoneal cavity by applying current to the body of a human or an animal and recording voltages at selected portions of the body chosen to reflect the anatomical boundaries of the peritoneal cavity. FIG. 2 shows one example of the location of current-providing electrodes (IRU, ILU, IRL and ILL) and measuring electrodes (MLL, MRL, MLB, and MRB) which achieve this result, where the peritoneal cavity (PC) is schematically shown as a shaded cylinder within the subject's torso.
The current can be applied and the voltages measured using various commercially available equipment for performing bioimpedance measurements, such as, the bioimpedance analysis devices sold by Xitron Technologies, Inc., San Diego, Calif. Generally, the use of alternating current is preferred, although direct current can be used if desired. The alternating current preferably has a frequency between about 5 kilohertz and about 500 kilohertz, a frequency of about 5 kilohertz being most preferred.
Bioimpedance analysis devices typically output both resistance and reactance values, i.e., the equipment outputs complex impedances. If desired, the reactance values and/or the magnitudes of the complex impedances can be used in the practice of the invention. However, it has been found that the real part of the impedance, i.e., the resistance value, is less sensitive to noise interference and thus its use is preferred. It should be understood, however, that the “R” values discussed above and set forth in the claims can be resistance values, reactance values, values for the magnitude of the complex impedance, or combinations thereof, as desired.
Preferably, apparatus of the type shown in FIG. 3 is used to apply current to the current-providing electrodes and to measure sequentially the voltages at the measuring electrodes on the right and left sides of the body. As shown in FIG. 3, the apparatus includes connectors 1, 2, 3, and 4 which serve to interface bioimpedance analysis device 5 to the eight electrodes used in the practice of the invention.
It should be noted that more than eight electrodes can be used in the practice of the invention if desired, e.g., more measuring electrodes and/or more current-providing electrodes can be used. In the limit, ring or band electrodes can be used. Calculation of the average resistance R in equation (1), as well as RA and RB in equations (2) and (3), will vary when electrode configurations having more than eight electrodes and/or one or more ring electrodes are used. For example, if more than two pairs of measuring electrodes are used, the average will be over all of the vertically aligned electrode pairs. For ring electrodes used for both the loin and buttock measuring electrodes, the averaging process is performed by the electrodes themselves, so that all that is needed is a determination of the voltage between the ring electrodes while current I is applied. The approaches for other combinations (e.g., a ring electrode for the loin measuring electrode and two or more discrete electrodes for the buttock measuring electrodes) will be evident to workers skilled in the art from the disclosure herein.
Connectors 1 and 2 in FIG. 3 serve as switches to provide left and right side voltage measurements. Specifically, when these connectors are in their upper positions in FIG. 3, left side voltage differences are measured, and when they are in their lower positions, right side voltage differences are measured. Connectors 3 and 4 carry current from the bioimpedance analysis device to the upper and lower current-providing electrodes, respectively.
The output of the bioimpedance analysis device, e.g., the difference in voltage between the left measuring electrodes when connectors 1 and 2 are in their upper positions, is transmitted to personal computer 6 through a suitable interface 7. Interface 7 and/or computer 6 can perform processing, e.g., digital signal processing, on the output from bioimpedance analysis device, e.g., low pass filtering to remove noise from the voltage signal. The amount of fluid introduced or removed from the subject's peritoneal cavity during the calibration procedure is inputted to the personal computer from the dialysis equipment through A/D converter 8.
The personal computer preferably includes a keyboard 9 for entry of commands from a user and a display 10 and printer 11 for outputting data indicative of the volume of fluid in the subject's peritoneal cavity. In addition, the system preferably includes a control module 12 which provides feedback to the dialysis equipment during, for example, a continuous peritoneal dialysis procedure in order to control, for example, the ultrafiltration rate.
The current-providing electrodes need to be outboard of the measuring electrodes so as to generate a readily measurable voltage difference between the measuring electrodes. As used herein, “outboard” means that relative to the peritoneal cavity, the current-providing electrodes are more distal than the measuring electrodes.
Preferably, the current-providing electrodes and the measuring electrodes are grouped together for application to the subject's body using a common support. Such grouping facilitates use of the equipment in, for example, an in-home environment. As just one example of such a grouping, the upper current-providing electrodes and the loin measuring electrodes can be carried by a single belt which is applied to the subject just below the rib cage. Similarly, the lower current-providing electrodes and the buttock measuring electrodes can be carried by a single belt or an elastic garment which is applied to or worn by the subject. Alternatively, two belts can be used for the lower current-providing electrodes and buttock measuring electrodes, said belts being applied high on the subject's upper thigh, preferably extending up into the buttock region. As a further alternative, the current-providing and measuring electrodes can be applied using adhesive patches, e.g., two patches for the upper current-providing electrodes and loin measuring electrodes and two patches for the lower current-providing electrodes and buttock measuring electrodes. With such supports, the current-providing electrodes are preferably at least about 5 centimeters outboard of the measuring electrodes.
FIG. 6A illustrates the use of a single common support for upper current-providing electrodes (IRU and ILU) and loin measuring electrodes (MRL and MLL). Electrodes IRU and ILU are used to inject current from the bioimpedance analysis device to the right side and left sides of the body, respectively. Electrodes MRL and MLL are used to measure voltage from the right and left sides, respectively. Electrodes IRU, ILU, MRL, and MLL are connected to the bioimpedance analysis device by lead 23.
The vertical distance between the two rows of electrodes is preferably about 5 cm and the width of the support is preferably about 8 cm. VELCRO fasteners 20,22 are used to close the support after it is applied to the patient's loins. Such fasteners allow the device to be used with patients having varying loin circumferences. Other types of fasteners can, of course, be used in the practice of the invention if desired.
FIGS. 6B and 6C illustrate the use of two common supports for the lower current-providing electrodes (IRL and ILL) and buttock measuring electrodes (MRB and MLB). These supports are placed on the patient's right and left buttocks respectively using VELCRO fasteners 20,22. The electrodes of the supports have a similar spacing to those of FIG. 6A. Likewise, the supports have a similar width. The current-providing and buttock measuring electrodes are connected to the bioimpedance analysis device by leads 24 and 25.
Both the current-providing and the measuring electrodes of FIGS. 6A, 6B, and 6C can be Ag/AgCl electrodes or can be composed of a conductive rubber which is affixed to the support.
The electrode system of FIG. 6 has the advantage that four injecting current electrodes and four measuring electrodes are integrated on three bands so that the patient does not need to place eight separate electrodes on his or her body. Further, the use of a common support leads to improved measurement accuracy because the electrodes can be more readily placed at their desired locations and are more likely to achieve a stable connection with the patient's skin.
Other arrangements can, of course, be used in the practice of the invention wherein, for example, the current-providing electrodes are significantly further outboard from the measuring electrodes, e.g., the current-providing electrodes can be placed on the subject's hands and feet as illustrated in FIG. 2.
As discussed above, current is applied simultaneously to the right and left current-providing electrodes while the left and right measurements are performed. This simultaneous current application is needed to take account of variations in the distribution of fluid within the peritoneal cavity for different subjects. Averaging of the right and left voltage measurements in calculating the volume of the peritoneal cavity is also of central importance in dealing with variations in fluid distribution in the peritoneal cavity, including changes in the distribution as a result of movement of the subject during a peritoneal dialysis procedure. It has been found that applying current on only one side, e.g., only on the side on which the voltage measurement is being made, can result in significant errors in the measurement of the volume of the peritoneal cavity for some subjects. Similarly, the use of voltage measurements from only one side of the body, rather than an average of left and right side measurements, results in a substantial loss in accuracy.
Preferably, the upper and lower current-providing electrodes (as well as the measuring electrodes) are on opposite sides of the subject's frontal plane so that current passes across that plane, although current-providing electrodes (and measuring electrodes) can be located on the same side of the frontal plane, e.g., on the subject's anterior surface, if desired.
Location of the measuring electrodes at the loin and buttock locations is also important in obtaining reliable measurements of peritoneal volumes of fluid. It has been found that locating the loin measuring electrodes substantially above or below the level of the diaphragm results in low sensitivity to changes in the peritoneal fluid volume. Similarly, locating the buttock measuring electrodes either too high or too low reduces the ability to detect the entire volume of fluid in the peritoneal cavity, especially when the subject is sitting and fluid collects at the bottom of the peritoneal cavity.
Because the distribution of peritoneal fluid varies between subjects, it is important to calibrate the voltages obtained from the measuring electrodes using a measured volume of fluid which is either inserted into the peritoneal cavity or removed therefrom. Such calibration also helps account for variations in body composition and anatomical configuration between different subjects, as well as variations in electrode placement and connection to the skin. The amount of fluid used for calibration is preferably at least one liter.
In particular, the calibration is used to determine the constant KP used in equation (1) above. Equations (1) to (3) include the effects of changes in the conductivity (σ) of the fluid in the peritoneal cavity. In a continuous peritoneal dialysis procedure such changes are very small and thus, if desired, a constant value for the conductivity can be used during calibration and measurement, e.g., a value of 21.3 mS/cm. Alternatively, the effects of changes in conductivity can be included in the calibration procedure through measurement of the conductivity of the measured volumes of fluid provided to or removed from the peritoneal cavity during calibration. Similarly, the effects of changes in conductivity during a peritoneal dialysis procedure can be taken into account by measuring the conductivity of the dialysate removed from the subject.
In certain preferred applications of the invention, the above techniques for measuring the volume of fluid in the peritoneal cavity are used to control a continuous peritoneal dialysis procedure, e.g., an overnight procedure whose duration is at least three hours and preferably at least six hours. In particular, measurements of the volume of fluid in the peritoneal cavity are made periodically or, preferably, continuously, and used to control such variables as the rate of inflow of dialysis fluid to the subject, the rate of outflow of dialysis fluid from the subject, and/or the composition of the dialysis fluid, e.g., the glucose concentration. For example, if an increase in fluid volume in the peritoneal cavity is detected, the amount of dialysis fluid supplied to the subject and/or the glucose concentration of that fluid can be decreased. The opposite changes can be made if a decrease in fluid volume is detected. In connection with these aspects of the invention, the conductivity of the fluid removed from the patient can be measured either periodically or continuously as a further measure of the course of the dialysis procedures and/or to fine tune the measurement of the volume of fluid in the peritoneal cavity, as discussed above. Various types of equipment known in the art for performing peritoneal dialysis, as well as for measuring the conductivity of fluids, can be used in the practice of these embodiments of the invention. For performing continuous peritoneal dialysis, two catheters, one for supplying dialysis fluid and the other for removing dialysate, can be used, or a single catheter having two lumens, i.e., an inflow lumen and an output lumen, can be employed.
It should be noted that in terms of clinical practice, fluid volumes in the peritoneal cavity only need to be determined to within about 0.25 liters. Accordingly, in most applications, only a single calibration needs to be performed at the beginning of a dialysis procedure, as is preferred when continuous peritoneal dialysis is performed. Of course, more frequent calibrations can be performed if desired.
The mathematical operations described herein can be performed using a variety of computers and software. For example, those operations can be performed using the VISUAL BASIC program of Microsoft's EXCEL software and a personal computer configured to run that program in accordance with the program manufacturer's specifications. The resulting programs can be stored on various storage media for use and/or distribution, e.g., the programs can be stored on removable magnetic discs, non-removable magnetic discs, or optical discs.
The overall computer system should include means for inputting data, e.g., interface 7 in FIG. 3, and means for outputting the results both in electronic and visual form, e.g., display 10 and printer 11 in FIG. 3. The output can also be stored on a disk drive, tape drive, or the like for further analysis and/or subsequent display.
Without intending to limit it in any manner, the present invention will be more fully described by the following examples. The materials and methods which are common to the examples are as follows.
Materials and Methods
Alternating current (5 kHz, 0.8 mA) was injected from alternate body sides in 1 minute intervals using four current-providing electrodes placed on both hands and feet. Four measuring electrodes were put on both sides of the loins and on the buttocks to measure impedance or, more specifically, resistance. FIG. 2 schematically shows the electrode placement that was used in collecting the data of the examples.
The subject (patient) was in a sitting body position during the measurement. The weights of drained and filling fluids were measured using an electronic scale.
Using the techniques of the invention, the volume of fluid in the peritoneal cavity was calculated from the average resistance measured on both body sides as described above. The measurements were calibrated through a determination of KP as also described above.
Switching between the right and left measurement electrodes was performed using the apparatus of FIG. 3. A XITRON bioimpedance analysis device was used to apply currents and to measure skin voltages.
Example 1
This example demonstrates that the bioimpedance techniques of the present invention reliably monitor changes in the volume of fluid in the peritoneal cavity of a subject undergoing peritoneal dialysis. It further demonstrates that the techniques of the invention reliably measure the accumulation of ultrafiltrate in the peritoneal cavity.
Four exchanges of fluid were performed on the subject. Specifically, in the first exchange, 2.3 liters of the subject's normal peritoneal fluid were drained from the subject's peritoneal cavity and replaced with 2.0 liters of dialysate. The dialysate was left in the peritoneal cavity for a dwell time of about 25 minutes, after which 1.5 liters were drained and replaced with 1.5 liters of fresh dialysate. This procedure was repeated two more times, after which 2.3 liters were drained from the peritoneal cavity and replaced with 2.0 liters of dialysate.
FIG. 4 is a trace of the volume of fluid in the peritoneal cavity calculated using equation (1) above. As can be seen in this figure, the technique of the invention accurately measured the various exchanges in peritoneal fluid. As can also be seen in FIG. 4, the technique detected the 0.35 liter ultrafiltration volume (UFV) which accumulated in the peritoneal cavity during the fourth dwell period which began at about 210 minutes into the experiment.
Example 2
This example illustrates the correlation between ultrafiltration volume (UFV) determined using equation (1) and measured UFV.
Ten subjects (patients) were used in this study, with one of the subjects being measured twice. For each subject, the normal peritoneal fluid was drained and replaced with 2 liters of dialysis fluid. After a dwell period of between 30 minutes and 2 hours, the volume of fluid in the peritoneal cavity was determined using the bioimpedance technique of the invention, i.e., equation (1) and the calibration procedures described above. The fluid in the peritoneal cavity was then removed and its volume measured. The ultrafiltration volume was defined as the difference between the volume of peritoneal fluid after the dwell period and the volume of dialysis fluid introduced at the beginning of the experiment, i.e., the difference between the final volume after the dwell period and 2 liters.
FIG. 5 is a plot of the results of this experiment, where the vertical axis is the ultrafiltration volume determined using equation (1) and the horizontal axis is the measured ultrafiltration volume. As can be seen in this figure, the values calculated in accordance with the technique of the invention are essentially linearly correlated with the measured values.
Example 3
This example illustrates the importance of locating the measuring electrodes in the subject's loin and buttock regions.
Twenty subjects (patients) were used in this study. For each subject, the normal peritoneal fluid was drained and replaced with dialysis fluid. The average volume of fluid drained was −2.15±0.48 liters. The average volume of dialysis fluid introduced into the peritoneal cavity was 2.1±0.2 liters. The change in fluid volume of the peritoneal cavity between the original state and the drained state (the drain volume) and between the drained stated and the filled state (fill volume) was measured using the technique of the invention with measuring electrodes placed on the subject's loins and buttocks. Measurements were also made with the measuring electrodes placed on the subject's hands and feet.
The drain and fill volumes measured using the technique of the invention were −2.0±0.5 liters and 1.7±0.45 liters, respectively. With the measuring electrodes placed on the hands and feet, the drain and fill volumes were −0.27±0.51 liters and 0.14±0.46 liters, respectively. The difference between the two measurement techniques was significant at the P<0.001 level. The superiority of the technique of the invention is evident from this data.
Although specific embodiments of the invention have been described and illustrated, it is to be understood that modifications can be made without departing from the invention's spirit and scope. For example, although the preferred applications of the invention are in the field of continuous peritoneal dialysis, the invention can also be used in batch wise peritoneal dialysis and in other applications in which the volume of fluid in the peritoneal cavity may be of interest, such as, in tests of peritoneal function.
A variety of other modifications which do not depart from the scope and spirit of the invention will be evident to persons of ordinary skill in the art from the disclosure herein. The following claims are intended to cover the specific embodiments set forth herein as well as such modifications, variations, and equivalents.

Claims (40)

1. A method for determining the volume of fluid in the peritoneal cavity of a subject comprising:
(a) placing measuring electrodes MLL and MRL on the loins of the subject, MLL being placed on the left loin and MRL being placed on the right loin, MLL and MRL defining a loin plane;
(b) placing measuring electrodes MLB and MRB on the buttocks of the subject, MLB being placed on the left buttock and MRB being placed on the right buttock, MLB and MRB defining a buttock plane;
(c) placing upper current-providing electrodes ILU and IRU on the subject, ILU being outboard of measuring electrode MLL and IRU being outboard of measuring electrode MRL;
(d) placing lower current-providing electrodes IRL and ILL on the subject, IRL being outboard of measuring electrode MRB and ILL being outboard of measuring electrode MLB;
(e) connecting upper current-providing electrode ILU to upper current-providing electrode IRU;
(f) connecting lower current-providing electrode ILL to lower current-providing electrode IRL;
(g) applying current I between the connected upper current-providing electrodes and the connected lower current-providing electrodes;
(h) measuring the voltage ΦL between MLL and MLB while current I is applied;
(i) measuring the voltage ΦR between MRL and MRB while current I is applied; and
(j) determining the volume V of fluid in the peritoneal cavity based on the equation:

V=(K P/σ)·(L P 2 /R)
where:
(1) KP is a subject-specific calibration constant;
(2) σ is the conductivity of the fluid in the peritoneal cavity;
(3) LP is the distance between the loin plane and the buttock plane; and
(4) R is the average of RL and RR, where

R LL/I, and

R RR/I.
2. The method of claim 1 wherein KP3 is determined by:
(i) performing steps (g), (h), and (i) before the introduction of a predetermined volume VC of dialysis fluid into the subject's peritoneal cavity to obtain ΦLB and ΦRB, said dialysis fluid having a conductivity σC;
(ii) performing steps (g), (h), and (i) after the introduction of a predetermined volume VC of dialysis fluid into the subject's peritoneal cavity to obtain ΦLA and ΦRA; and
(iii) determining KP from the equation:

K P=(σC)·(V C /L P 2)·(R B R A)/(R B −R A)
where
RB=(ΦLBRB)/(2I), and
RA=(ΦLARA)/(2I).
3. The method of claim 2 where VC is at least one liter.
4. The method of claim 1 wherein KP is determined by:
(i) introducing dialysis fluid into the subject's peritoneal cavity;
(ii) performing steps (g), (h), and (i) to obtain ΦLB and ΦRB;
(iii) removing fluid from the subject's peritoneal cavity;
(iv) performing steps (g), (h), and (i) to obtain ΦLA and ΦRA; and
(v) determining KP from the equation:

K P=(σC)·(V C /L P 2)·(R B R A)/(R A −R B)
where
RB=(ΦLBRB)/(2I),
RA=(ΦLARA)/(2I), and
VC and σC are, respectively, the volume and conductivity of the fluid removed in step (iii).
5. The method of claim 4 where VC is at least one liter.
6. The method of claim 1 wherein the current I is alternating current having a frequency in the range from about 5 kilohertz to about 500 kilohertz.
7. The method of claim 6 wherein the current I has a frequency of about 5 kilohertz.
8. The method of claim 1 wherein the upper current-providing electrodes are placed on the subject's hands and the lower current-providing electrodes are placed on the subject's feet.
9. The method of claim 1 wherein the upper current-providing electrodes are placed on the subject's trunk and the tower current-providing electrodes are placed on the subject's thighs.
10. The method of claim 1 wherein the upper current-providing electrodes and the measuring electrodes MLL and MRL are carried by a common support which is placed on the subject's trunk.
11. The method of claim 1 wherein the lower current-providing electrode ILL and the measuring electrode MLB are carried by a first common support which is placed at least in part on the subject's left leg and the lower current-providing electrode IRL and the measuring electrode MRB are carried by a second common support which is placed at least in part on the subjects right leg.
12. A method of controlling a peritoneal dialysis procedure comprising:
(A) continuously flowing dialysis fluid through a subject's peritoneal cavity;
(B) while step (A) is being performed, determining the volume of fluid in the peritoneal cavity by a bioimpedance measurement directed at the peritoneal cavity; and
(C) controlling step (A) based on the volume of fluid in the peritoneal cavity determined in step (B).
13. The method of claim 12 wherein step (B) is performed by:
(a) placing measuring electrodes MLL and MRL on the loins of the subject, MLL being placed on the left loin and MRL being placed on the right loin, MLL and MRL defining a loin plane;
(b) placing measuring electrodes MLB and MRB on the buttocks of the subject, MLB being placed on the left buttock and MRB being placed on the right buttock, MLB and MRB defining a buttock plane;
(c) placing upper current-providing electrodes ILU and IRU on the subject, ILU being outboard of measuring electrode MLL and IRU being outboard of measuring electrode MRL;
(d) placing lower current-providing electrodes IRL and ILL on the subject, IRL being outboard of measuring electrode MRB and ILL being outboard of measuring electrode MLB;
(e) connecting upper current-providing electrode ILU to upper current-providing electrode IRU;
(f) connecting lower current-providing electrode ILL to lower current-providing electrode IRL;
(g) applying current I between the connected upper current-providing electrodes and the connected lower current-providing electrodes;
(h) measuring the voltage ΦL between MLL and MLB while current I is applied;
(i) measuring the voltage ΦR between MRL and MRB while current I is applied; and
(j) determining the volume V of fluid in the peritoneal cavity based on the equation:

V=(K P/σ)·(L P 2 /R)
where:
(1) KP is a subject specific calibration constant;
(2) σ is the conductivity of the fluid in the peritoneal cavity;
(3) LP is the distance between the loin plane and the buttock plane; and
(4) R is the average of RL and RR, where

R LL/I, and

R RR/I.
14. The method of claim 12 where the rate of flow of dialysis fluid into, out of, or both into and out of the peritoneal cavity is controlled in step (C).
15. The method of claim 12 where the composition of the dialysis fluid is controlled in step (C).
16. The method of claim 12 including the additional step of determining the conductivity of dialysis fluid removed from the subject while step (A) is being performed.
17. The method of claim 12 wherein in step (A), the continuous flowing of dialysis fluid through the subject's peritoneal cavity is performed for a period of at least three hours and step (B) is performed at least at regular intervals throughout said period.
18. The method of claim 17 wherein step (B) is performed substantially continuously throughout said period.
19. The method of claim 12 wherein in step (A), the continuous flowing of dialysis fluid through the subject's peritoneal cavity is performed for a period of at least six hours and step (B) is performed at least at regular intervals throughout said period.
20. The method of claim 19 wherein step (B) is performed substantially continuously throughout said period.
21. The method of claim 12 wherein in step (B), the bioimpedance measurement employs measuring electrodes located in the subject's loin and buttock regions.
22. Apparatus for determining the volume of fluid in the peritoneal cavity of a subject comprising:
(a) measuring electrodes MLL and MRL for placement on the loins of the subject, MLL to be placed on the left loin and MRL to be placed on the right loin such that, when so placed, MLL and MRL define a loin plane;
(b) measuring electrodes MLB and MRB for placement on the buttocks of the subject, MLB to be placed on the left buttock and MRB to be placed on the right buttock such that, when so placed, MLB and MRB define a buttock plane;
(c) upper current-providing electrodes ILU and IRU for placement on the subject;
(d) lower current-providing electrodes IRL and ILL for placement on the subject;
(e) means for connecting upper current-providing electrode ILU to upper current-providing electrode IRU;
(f) means for connecting lower current-providing electrode ILL to lower current-providing electrode IRL;
(g) means for applying a current I between the connected upper current-providing electrodes and the connected lower current-providing electrodes;
(h) means for measuring the voltage ΦL between MLL and MLB while current I is applied;
(i) means for measuring the voltage ΦR between MRL and MRB while current I is applied; and
(j) means for determining the volume V of fluid in the peritoneal cavity based on the equation:

V=(K P/σ)·(L P 2 /R)
where:
(1) KP is a subject-specific calibration constant;
(2) σ is the conductivity of the fluid in the peritoneal cavity;
(3) LP is the distance between the loin plane and the buttock plane; and
(4) R is the average of RL and RR, where
RLL/I, and
RRR/I.
23. The apparatus of claim 22 further comprising means for determining KP, said means comprising:
(i) means for determining the voltage ΦLB between MLL and MLB and the voltage ΦRB between MRL and MRB while current I is applied, said determination being made before the introduction of a predetermined volume VC of dialysis fluid into the subject's peritoneal cavity, said dialysis fluid having a conductivity ac;
(ii) means for determining the voltage ΦLA between MLL and MLB and the voltage ΦRA between MRL and MRB while current I is applied, said determination being made after the introduction of a predetermined volume VC of dialysis fluid into the subject's peritoneal cavity; and
(iii) means for determining KP from the equation:

K P=(σC)·(V C /L P 2)·(R B R A)/(R B −R A)
where
RB=(ΦLBRB)/(2I), and
RA=(ΦLARA)/(2I).
24. The apparatus of claim 22 further comprising means for determining KP, said means comprising:
(i) means for introducing dialysis fluid into the subject's peritoneal cavity;
(ii) means for determining the voltage ΦLB between MLL and MLB and the voltage ΦRB between MRL and MRB while current I is applied, said determination being made before removal of fluid from the subject's peritoneal cavity;
(iii) means for removing fluid from the subject's peritoneal cavity;
(iv) means for measuring the volume VC of fluid removed from the subject's peritoneal cavity;
(v) means for determining the voltage ΦLA between MLL and MLB and the voltage ΦRA between MRL and MRB while current I is applied, said determination being made after the removal of the volume VC of fluid from the subject's peritoneal cavity; and
(vi) means for determining KP from the equation:

K P=(σC)·(V C /L P 2)·(R B R A)/(R A −R B)
where

R B=(ΦLBRB)/(2I),

RA=(ΦLARA)/(2I), and
σC is the conductivity of the fluid removed from the subject's peritoneal cavity.
25. The apparatus of claim 22 wherein the current I is alternating current having a frequency in the range from about 5 kilohertz to about 500 kilohertz.
26. The apparatus of claim 25 wherein the current I has a frequency of about 5 kilohertz.
27. The apparatus of claim 22 further comprising a support for carrying the upper current-providing electrodes and the measuring electrodes MLL and MRL.
28. The apparatus of claim 22 further comprising a first support for carrying the lower current-providing electrode ILL and the measuring electrode MLB and a second support for carrying the lower current-providing electrode IRL and the measuring electrode MRB.
29. Apparatus for performing a peritoneal dialysis procedure comprising:
(A) first means for continuously flowing dialysis fluid through a subject's peritoneal cavity, said flowing of dialysis fluid being capable of causing the accumulation of ultrafiltrate from the subject in the peritoneal cavity;
(B) second means for determining the volume of fluid in the peritoneal cavity while dialysis fluid is flowed through the subject's peritoneal cavity, said second means comprising means for performing a bioimpedance measurement directed at the peritoneal cavity; and
(C) third means for controlling the first means based on the volume of fluid in the peritoneal cavity determined by the second means.
30. The apparatus of claim 29 wherein the means for performing a bioimpedance measurement directed at the peritoneal cavity comprises:
(a) measuring electrodes MLL and MRL for placement on the loins of the subject, MLL to be placed on the left loin and MRL to be placed on the right loin such that, when so placed, MLL and MRL define a loin plane;
(b) measuring electrodes MLB and MRB for placement on the buttocks of the subject, MLB to be placed on the left buttock and MRB to be placed on the right buttock such that, when so placed, MLB and MRB define a buttock plane;
(c) upper current-providing electrodes ILU and IRU for placement on the subject;
(d) lower current-providing electrodes IRL and ILL for placement on the subject;
(e) means for connecting upper current-providing electrode ILU to upper current-providing electrode IRU;
(f) means for connecting lower current-providing electrode ILL to lower current-providing electrode IRL;
(g) means for applying a current I between the connected upper current-providing electrodes and the connected lower current-providing electrodes;
(h) means for measuring the voltage ΦL between MLL and MLB while current I is applied;
(i) means for measuring the voltage ΦR between MRL and MRB while current I is applied; and
(j) means for determining the volume V of fluid in the peritoneal cavity based on the equation:

V=(K P/σ)·(L P 2 /R)
where:
(1) KP is a subject-specific calibration constant;
(2) σ is the conductivity of the fluid in the peritoneal cavity;
(3) LP is the distance between the loin plane and the buttock plane; and
(4) R is the average of RL and RR, where

R LL/I, and

R RR/I.
31. The apparatus of claim 29 wherein the third means controls the ultrafiltration rate of the first means.
32. The apparatus of claim 29 wherein the third means controls the rate at which the first means flows dialysis fluid through the subject's peritoneal cavity.
33. The apparatus of claim 29 wherein the third means controls the composition of the dialysis fluid which the first means flows through the subject's peritoneal cavity.
34. The apparatus of claim 29 wherein the third means includes means for determining the conductivity of the dialysis fluid removed from the subject by the first means.
35. An article of manufacture comprising a computer usable medium having computer readable code means embodied therein for:
(a) determining the volume V of fluid in the peritoneal cavity of a subject based on the equation:

V=(K P/σ)·(L P 2 /R)
where:
(1) KP is a subject-specific calibration constant
(2) σ is the conductivity of the fluid in the peritoneal cavity:
(3) LP is the distance between a loin plane and a buttock plane of the subject, the loin plane being established by the locations of measuring electrodes MLL and MRL placed on the subject's left and right loins, respectively, and the buttock plane being established by measuring electrodes MLB and MRB placed on the subject's left and right buttocks, respectively; and
(4) R is the average of RL and RR, where
(i) RLL/I,
(ii) RRR/I, and
(iii) I is an applied current between connected upper current-providing electrodes ILU IRU and connected lower current-providing electrodes IRL and ILL placed on the subject with ILU and IRU being outboard of measuring electrode MLL, IRU being outboard of measuring electrode MRL, IRL being outboard of measuring electrode MRB and ILL being outboard of measuring electrode MLB, and
(iv) ΦL and ΦR are measured voltages between MLL and MLB and between MRL and MRB, respectively, while current I is applied; and
(b) displaying the value of the calculated volume V to the subject and/or to a care provider and/or controlling the flow of dialysis fluid through the suibject's peritoneal cavity using the calculated volume V.
36. An article of manufacture comprising a computer usable medium having computer readable code means embodied therein for:
(a) determining a subject-specific for use in determining the volume of fluid in the subject's peritoneal cavity calibration constant KP from the equation:

K P=(σC)·(V C /L P 2)·(R B R A)/(R B −R A)
where
(i) RB=(ΦLBRB)/(2I);
(ii) RA=(ΦLARA)/(2I);
(iii) VC and σC are, respectively, the volume and conductivity of a predetermined volume of dialysis fluid;
(iv) LP is the distance between a loin plane and a buttock plane of the subject, the loin plane being established by the locations of measuring electrodes MLL and MRL placed on the subject's left and right loins, respectively, and the buttock plane being established by measuring electrodes MLB and MRB placed on the subject's left and right buttocks, respectively;
(v) I is an applied current between connected upper current-providing electrodes ILU and IRU connected lower current-providing electrodes IRL and ILL placed on the subject with ILU being outboard of measuring electrode MLL, IRU being outboard of measuring electrode MRL, IRL being outboard of measuring electrode MRB and ILL being outboard of measuring electrode MLB,
(vi) ΦLA and ΦRA are measured voltages between MLL and MLB and between MRL and MRB, respectively, obtained before introduction of the predetermined volume of dialysis fluid into the subject's peritoneal cavity and while current I is applied; and
(vii) ΦLA and ΦRA are measured voltages between MLL and MLB and between MRL and MRB, respectively, obtained after introduction of the predetermined volume of dialysis fluid into the subject's peritoneal cavity and while current I is applied; and
(b) displaying the value of the calculated subject-specific calibration constant KP to the subject and/or to a care provider and/or controlling the flow of dialysis fluid through the subject's peritoneal cavity using the calculated subject-specific calibration constant KP.
37. An article of manufacture comprising a computer usable medium having computer readable code means embodied therein for:
(a) determining a subject-specific for use in determining the volume of fluid in the subject's peritoneal cavity calibration constant KP from the equation:

K P=(σC)·(V C /L P 2)·(R B R A)/(R B −R A)
where
(i) RB=(ΦLBRB)/(2I);
(ii) RA=(ΦLARA)/(2I);
(iii) LP is the distance between a loin plane and a buttock plane of the subject, the loin plane being established by the locations of measuring electrodes MLL and MRL placed on the subject's left and right loins, respectively, and the buttock plane being established by measuring electrodes MLB and MRB placed on the subject's left and right buttocks, respectively;
(iv) I is an applied current between connected upper current-providing electrodes ILU and IRU and connected lower current-providing electrodes IRL and ILL placed on the subject with ILU being outboard of measuring electrode MLL, IRU being outboard of measuring electrode MRL, IRL being outboard of measuring electrode MRB and ILL being outboard of measuring electrode MLB,
(v) ΦLB and ΦRB are measured voltages between MLL and MLB and between MRL and MRB, respectively, obtained after introduction of dialysis fluid into the subject's peritoneal cavity and while current I is applied:
(vi) ΦLA and ΦRA are measured voltages between MLL and MLB and between MRL and MRB, respectively, obtained after removal of fluid from the subject's peritoneal cavity and while current I is applied; and
(vii) VC and σC are, respectively, the volume and conductivity of the fluid removed from the subject's peritoneal cavity; and
(b) displaying the value of the calculated subject-specific calibration constant KP to the subject and/or to a care provider and/or controlling the flow of dialysis fluid through the subject's peritoneal cavity using the calculated subject-specific calibration constant KP.
38. Apparatus comprising a computer which has been programmed to:
(a) determine the volume V of fluid in the peritoneal cavity of a subject based on the equation:

V=(K P/σ)·(L P 2 /R)
where:
(1) KP is a subject-specific calibration constant,
(2) σ is the conductivity of the fluid in the peritoneal cavity:
(3) LP is the distance between a loin plane and a buttock plane of the subject, the loin plane being established by the locations of measuring electrodes MLL, and MRL, placed on the subject's left and right loins, respectively, and the buttock plane being established by measuring electrodes MLB and MRB placed on the subject's left and right buttocks, respectively; and
(4) R is the average of RL and RR, where
(i) RLL/I,
(ii) RRR/I, and
(iii) I is an applied current between connected upper current-providing electrodes ILU and IRU and connected lower current-providing electrodes IRL and ILL placed on the subject with ILU being outboard of measuring electrode MLL, IRU being outboard of measuring electrode MRL, IRL being outboard of measuring electrode MRB and ILL being outboard of measuring electrode MLB, and
(iv) ΦL and ΦR are measured voltages between MLL and MLB and between MRL and MRB, respectively, while current I is applied; and
(b) display the value of the calculated volume V to the subject and/or to a care provider and/or control the flow of dialysis fluid through the subject's peritoneal cavity using the calculated volume V.
39. Apparatus comprising a computer which has been programmed to:
(a) determine a subject-specific for use in determining the volume of fluid in the subject's peritoneal cavity calibration constant KP from the equation:

K P=(σC)·(V C /L P 2)·(R B R A)/(R B −R A)
where
(i) RB=(ΦLBRB)/(2I);
(ii) RA=(ΦLARA)/(2I);
(iii) VC and σC are, respectively, the volume and conductivity of a predetermined volume of dialysis fluid;
(iv) LP is the distance between a loin plane and a buttock plane of the subject, the loin plane being established by the locations of measuring electrodes MLL and MRL placed on the subject's left and right loins, respectively, and the buttock plane being established by measuring electrodes MLB and MRB placed on the subject's left and right buttocks, respectively;
(v) I is an applied current between connected upper current-providing electrodes ILU a IRU and connected lower current-providing electrodes IRL and ILL placed on the subject with ILU being outboard of measuring electrode MLL, IRU being outboard of measuring electrode MRL, IRL being outboard of measuring electrode MRB and ILL being outboard of measuring electrode MLB,
(vi) ΦLB and ΦRB are measured voltages between MLL and MLB and between MRL and MRB, respectively, obtained before introduction of the predetermined volume of dialysis fluid into the subject's peritoneal cavity and while current I is applied; and
(vii) ΦLA and ΦRA are measured voltages between MLL and MLB and between MRL and MRB, respectively, obtained after introduction of the predetermined volume of dialysis fluid into the subject's peritoneal cavity and while current I is applied; and
(b) display the value of the calculated subject-specific calibration constant KP to the subject and/or to a care provider and/or control the flow of dialysis fluid through the subject's peritoneal cavity using the calculated subject-specific calibration constant KP.
40. Apparatus comprising a computer which has been programmed to:
(a) determine a subject-specific for use in determining the volume of fluid in the subject's peritoneal cavity calibration constant KP from the equation:

K P=(σC)·(V C /L P 2)·(R B R A)/(R B −R A)
where
(i) RB=(ΦLBRB)/(2I);
(ii) RA=(ΦLARA)/(2I);
(iii) LP is the distance between a loin plane and a buttock plane of the subject, the loin plane being established by the locations of measuring electrodes MLL and MRL placed on the subject's left and right loins, respectively, and the buttock plane being established by measuring electrodes MLB and MRB placed on the subject's left and right buttocks, respectively
(iv) I is an applied current between connected upper current-providing electrodes ILU and IRU and connected lower current-providing electrodes IRL and ILL placed on the subject with ILU being outboard of measuring electrode MLL, IRU being outboard of measuring electrode MRL, IRL being outboard of measuring electrode MRB and ILL being outboard of measuring electrode MLB,
(v) ΦLB and ΦRB are measured voltages between MLL and MLB and between MRL and MRB, respectively, obtained after introduction of dialysis fluid into the subject's peritoneal cavity and while current I is applied;
(vi) ΦLA and ΦRA are measured voltages between MLL and MLB and between MRL and MRB, respectively, obtained after removal of fluid from the subject's peritoneal cavity and while current I is applied; and
(vii) VC and σC are, respectively, the volume and conductivity of the fluid removed from the subject's peritoneal cavity; and
(b) display the value of the calculated subject-specific calibration constant KP to the subject and/or to a care provider and/or control the flow of dialysis fluid through the subject's peritoneal cavity using the calculated subject-specific calibration constant KP.
US10/089,831 1999-10-05 2000-09-29 Methods and apparatus for measuring the volume of fluid in the peritoneal cavity Expired - Lifetime US7354417B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/089,831 US7354417B1 (en) 1999-10-05 2000-09-29 Methods and apparatus for measuring the volume of fluid in the peritoneal cavity

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15778599P 1999-10-05 1999-10-05
PCT/US2000/027048 WO2001024847A1 (en) 1999-10-05 2000-09-29 Methods and apparatus for measuring the volume of fluid in the peritoneal cavity
US10/089,831 US7354417B1 (en) 1999-10-05 2000-09-29 Methods and apparatus for measuring the volume of fluid in the peritoneal cavity

Publications (1)

Publication Number Publication Date
US7354417B1 true US7354417B1 (en) 2008-04-08

Family

ID=39263446

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/089,831 Expired - Lifetime US7354417B1 (en) 1999-10-05 2000-09-29 Methods and apparatus for measuring the volume of fluid in the peritoneal cavity

Country Status (1)

Country Link
US (1) US7354417B1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060264775A1 (en) * 2003-03-14 2006-11-23 Mills Gary N Methods of and apparatus for determining fluid volume presence in mammalian tissue
US20090043222A1 (en) * 2005-10-11 2009-02-12 Scott Chetham Hydration status monitoring
US20090275881A1 (en) * 2008-05-02 2009-11-05 Baxter International Inc. Optimizing therapy outcomes for peritoneal dialysis
US20100198138A1 (en) * 2009-01-30 2010-08-05 Baxter International Inc. Transfer sets for therapy optimization
US20100298662A1 (en) * 2009-05-20 2010-11-25 Baxter International Inc. System and method for automated data collection of twenty-four hour ultrafiltration and other patient parameters using wired or wireless technology
US20110093294A1 (en) * 2009-10-16 2011-04-21 Baxter International Inc. Peritoneal dialysis optimized using a patient hand-held scanning device
DE102011108252A1 (en) * 2011-07-22 2013-01-24 Rheinisch-Westfälische Technische Hochschule Aachen Method and device for monitoring the urinary bladder level of a patient
WO2013185080A1 (en) 2012-06-08 2013-12-12 Fresenius Medical Care Holdings, Inc. System and method of monitoring and control of ultrafiltration volume during peritoneal dialysis using segmental bioimpedance
US8871095B2 (en) 2008-07-09 2014-10-28 Baxter International Inc. Dialysis method including wireless patient data
US8882700B2 (en) 2008-05-02 2014-11-11 Baxter International Inc. Smart patient transfer set for peritoneal dialysis
US20150164370A1 (en) * 2012-04-26 2015-06-18 Fresenius Medical Care Deutschland Gmbh Device having electrodes for bio-impedance measurement for dialysis
CN108055823A (en) * 2015-07-16 2018-05-18 伊派迪迈德公司 Fluid levels determine
US20210106741A1 (en) * 2019-10-10 2021-04-15 Fresenius Medical Care Holdings, Inc. Systems and methods for monitoring fluid volumes during peritoneal dialysis
US11179516B2 (en) 2017-06-22 2021-11-23 Baxter International Inc. Systems and methods for incorporating patient pressure into medical fluid delivery

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3871359A (en) * 1973-06-25 1975-03-18 Interscience Technology Corp Impedance measuring system
US4008712A (en) 1975-11-14 1977-02-22 J. M. Richards Laboratories Method for monitoring body characteristics
US4059169A (en) * 1976-02-09 1977-11-22 Hagen Winston H Monitor for biological volume changes
US4450527A (en) 1982-06-29 1984-05-22 Bomed Medical Mfg. Ltd. Noninvasive continuous cardiac output monitor
US4793362A (en) 1982-04-22 1988-12-27 Karolinska Institutet Method and apparatus for monitoring the fluid balance of the body
US4911175A (en) 1987-09-17 1990-03-27 Diana Twyman Method for measuring total body cell mass and total extracellular mass by bioelectrical resistance and reactance
US4947862A (en) 1988-10-28 1990-08-14 Danninger Medical Technology, Inc. Body composition analyzer
WO1997001303A1 (en) 1995-06-24 1997-01-16 Ki Chul Cha Apparatus and method for analyzing body composition using a new electrode system based on bioelectrical impedance analysis
US5643201A (en) * 1984-07-09 1997-07-01 Peabody; Alan M. Continuous peritoneal dialysis apparatus
US5735284A (en) 1992-06-24 1998-04-07 N.I. Medical Ltd. Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body
US5788643A (en) 1997-04-22 1998-08-04 Zymed Medical Instrumentation, Inc. Process for monitoring patients with chronic congestive heart failure
US5791349A (en) 1996-04-17 1998-08-11 Urohealth, Inc. Apparatus and method of bioelectrical impedance analysis of blood flow

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3871359A (en) * 1973-06-25 1975-03-18 Interscience Technology Corp Impedance measuring system
US4008712A (en) 1975-11-14 1977-02-22 J. M. Richards Laboratories Method for monitoring body characteristics
US4059169A (en) * 1976-02-09 1977-11-22 Hagen Winston H Monitor for biological volume changes
US4793362A (en) 1982-04-22 1988-12-27 Karolinska Institutet Method and apparatus for monitoring the fluid balance of the body
US4450527A (en) 1982-06-29 1984-05-22 Bomed Medical Mfg. Ltd. Noninvasive continuous cardiac output monitor
US5643201A (en) * 1984-07-09 1997-07-01 Peabody; Alan M. Continuous peritoneal dialysis apparatus
US4911175A (en) 1987-09-17 1990-03-27 Diana Twyman Method for measuring total body cell mass and total extracellular mass by bioelectrical resistance and reactance
US4947862A (en) 1988-10-28 1990-08-14 Danninger Medical Technology, Inc. Body composition analyzer
US5735284A (en) 1992-06-24 1998-04-07 N.I. Medical Ltd. Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body
WO1997001303A1 (en) 1995-06-24 1997-01-16 Ki Chul Cha Apparatus and method for analyzing body composition using a new electrode system based on bioelectrical impedance analysis
US5791349A (en) 1996-04-17 1998-08-11 Urohealth, Inc. Apparatus and method of bioelectrical impedance analysis of blood flow
US5788643A (en) 1997-04-22 1998-08-04 Zymed Medical Instrumentation, Inc. Process for monitoring patients with chronic congestive heart failure

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
Rallison et al., "Errors in estimating peritoneal fluid by bioelectrical impedance analysis and total body electrical conductivity," Journal of the American College of Nutrition, 12:66-72, 1993.
Schneditz et al., "Kinetics of fluid removal during hemodialysis (HD) measured by segmental bioimpendance," J Amer Soc Nephrol., 1997, A1334.
Zhu et al., " Estimation of trunk extracellular volume by bioimpedance," Proc IEEE EMBS, 1998, 20:3104-3107.
Zhu et al., "Changes in body extracellular fluid during periotoneal dialysis measured by segmental bioimpendance analysis," Proceedings of the 15<SUP>th </SUP>International Congress of Nephrology, Buenos Aires, Argentina, May 2-6, 1999.
Zhu et al., "Changes in extracellular volume during hemodialysis and ultrafiltration estimated from sum of segmental bioimpedance analysis," ASLAO Abstracts, Annual Conference, New York, Apr. 23-25, 1998, 73A.
Zhu et al., "Changes in segmental extracellular volume (ECV) and Blood volume (BV) during ultrafiltration (UF)," J Amer Soc Nephrol., 1998, A0967.
Zhu et al., "Continuous measurement of segmental and whole body bio-impendance," Proc IEEE EMBS, 1997, 19:2086-2088.
Zhu et al., "Dynamics of segmental extracellular volumes during changes in body position by bioimpendance analysis," J. Appl. Physiol, 1998, 85:497-504.
Zhu et al., "Effect of body position on estimation of extracellular volume (ECV) using whole body and segmental bioimpendance analysis," ASIAO Abstracts, Annual Conference, New York, Apr. 23-25, 1998, 85A.
Zhu et al., "Low central fraction of extracellular volume (Fc) relates to hypotension during hemodialysis (HD) and ultrafiltration (UF)," J Amer Soc Nephrol., 1998, A0966.
Zhu et al., "Validation of changes in extracellular volume measured during hemodialysis using a segmental bioimpendance technique," ASAIO Journal, 1998, 44:M541-M545.

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060264775A1 (en) * 2003-03-14 2006-11-23 Mills Gary N Methods of and apparatus for determining fluid volume presence in mammalian tissue
US20090043222A1 (en) * 2005-10-11 2009-02-12 Scott Chetham Hydration status monitoring
US11612332B2 (en) 2005-10-11 2023-03-28 Impedimed Limited Hydration status monitoring
US9724012B2 (en) * 2005-10-11 2017-08-08 Impedimed Limited Hydration status monitoring
US8882700B2 (en) 2008-05-02 2014-11-11 Baxter International Inc. Smart patient transfer set for peritoneal dialysis
US20090275881A1 (en) * 2008-05-02 2009-11-05 Baxter International Inc. Optimizing therapy outcomes for peritoneal dialysis
US9348975B2 (en) 2008-05-02 2016-05-24 Baxter International Inc. Optimizing therapy outcomes for peritoneal dialysis
US10307524B2 (en) 2008-07-09 2019-06-04 Baxter International Inc. Dialysis method and system including wireless patient data
US10272190B2 (en) 2008-07-09 2019-04-30 Baxter International Inc. Renal therapy system including a blood pressure monitor
US10265455B2 (en) 2008-07-09 2019-04-23 Baxter International Inc. Dialysis system including wireless sensor data
US10016554B2 (en) 2008-07-09 2018-07-10 Baxter International Inc. Dialysis system including wireless patient data
US8871095B2 (en) 2008-07-09 2014-10-28 Baxter International Inc. Dialysis method including wireless patient data
US8636706B2 (en) 2009-01-30 2014-01-28 Baxter International Inc. Transfer sets for therapy optimization
US20100198138A1 (en) * 2009-01-30 2010-08-05 Baxter International Inc. Transfer sets for therapy optimization
US8377012B2 (en) 2009-01-30 2013-02-19 Baxter International Inc. Transfer sets for therapy optimization
US9381290B2 (en) 2009-05-20 2016-07-05 Baxter International Inc. System and method for pairing a dialysis machine with peripheral devices
US11752245B2 (en) 2009-05-20 2023-09-12 Baxter International Inc. System and method for automated collection of dialysis data
US10314958B2 (en) 2009-05-20 2019-06-11 Baxter International Inc. System and method for pairing a dialysis machine with peripheral devices
US20100298662A1 (en) * 2009-05-20 2010-11-25 Baxter International Inc. System and method for automated data collection of twenty-four hour ultrafiltration and other patient parameters using wired or wireless technology
US8282829B2 (en) 2009-05-20 2012-10-09 Baxter International Inc. System and method for automated data collection of twenty-four hour ultrafiltration and other patient parameters using wired or wireless technology
US11027053B2 (en) 2009-05-20 2021-06-08 Baxter International Inc. Method for pairing a dialysis machine with peripheral devices
US11058809B2 (en) 2009-10-16 2021-07-13 Baxter International Inc. Optimizing peritoneal dialysis using a patient hand-held scanning device
US10449284B2 (en) 2009-10-16 2019-10-22 Baxter Interntional Inc. Optimizing peritoneal dialysis using a patient hand-held scanning device
US11607479B2 (en) 2009-10-16 2023-03-21 Baxter International Inc. Optimizing peritoneal dialysis using a patient hand-held scanning device
US20110093294A1 (en) * 2009-10-16 2011-04-21 Baxter International Inc. Peritoneal dialysis optimized using a patient hand-held scanning device
US9020827B2 (en) 2009-10-16 2015-04-28 Baxter International Inc. Peritoneal dialysis optimized using a patient hand-held scanning device
DE102011108252A1 (en) * 2011-07-22 2013-01-24 Rheinisch-Westfälische Technische Hochschule Aachen Method and device for monitoring the urinary bladder level of a patient
US10376176B2 (en) 2012-04-26 2019-08-13 Fresenius Medical Care Deutschland Gmbh Device having electrodes for bio-impedance measurement for dialysis
US20150164370A1 (en) * 2012-04-26 2015-06-18 Fresenius Medical Care Deutschland Gmbh Device having electrodes for bio-impedance measurement for dialysis
WO2013185080A1 (en) 2012-06-08 2013-12-12 Fresenius Medical Care Holdings, Inc. System and method of monitoring and control of ultrafiltration volume during peritoneal dialysis using segmental bioimpedance
AU2013271403B2 (en) * 2012-06-08 2016-07-07 Fresenius Medical Care Holdings, Inc. System and method of monitoring and control of ultrafiltration volume during peritoneal dialysis using segmental bioimpedance
US10960122B2 (en) * 2012-06-08 2021-03-30 Fresenius Medical Care Holdings, Inc. System and method of monitoring and control of ultrafiltration volume during peritoneal dialysis using segmental bioimpedance
KR20150022986A (en) * 2012-06-08 2015-03-04 프레제니우스 메디칼 케어 홀딩스 인코퍼레이티드 System and method of monitoring and control of ultrafiltration volume during peritoneal dialysis using segmental bioimpedance
US20210178042A1 (en) * 2012-06-08 2021-06-17 Fresenius Medical Care Holdings, Inc. System and method of monitoring and control of ultrafiltration volume during peritoneal dialysis using segmental bioimpedance
EP2858569A4 (en) * 2012-06-08 2016-01-20 Fresenius Med Care Hldg Inc System and method of monitoring and control of ultrafiltration volume during peritoneal dialysis using segmental bioimpedance
JP2015519967A (en) * 2012-06-08 2015-07-16 フレゼニウス メディカル ケア ホールディングス インコーポレイテッド System and method for monitoring and controlling ultrafiltration volume during peritoneal dialysis using fractional bioimpedance
US20150133854A1 (en) * 2012-06-08 2015-05-14 Fresenius Medical Care Holdings, Inc. System and method of monitoring and control of ultrafiltration volume during peritoneal dialysis using segmental bioimpedance
CN104411242A (en) * 2012-06-08 2015-03-11 弗雷泽纽斯医疗保健控股有限公司 System and method of monitoring and control of ultrafiltration volume during peritoneal dialysis using segmental bioimpedance
CN108055823A (en) * 2015-07-16 2018-05-18 伊派迪迈德公司 Fluid levels determine
US11179516B2 (en) 2017-06-22 2021-11-23 Baxter International Inc. Systems and methods for incorporating patient pressure into medical fluid delivery
US20210106741A1 (en) * 2019-10-10 2021-04-15 Fresenius Medical Care Holdings, Inc. Systems and methods for monitoring fluid volumes during peritoneal dialysis
WO2021072149A1 (en) * 2019-10-10 2021-04-15 Fresenius Medical Care Holdings, Inc. Systems and methods for monitoring fluid volumes during peritoneal dialysis

Similar Documents

Publication Publication Date Title
US9743843B2 (en) Patient supporting device, treatment apparatus with a patient supporting device and corresponding method for controlling and/or regulating a medical treatment device
US7354417B1 (en) Methods and apparatus for measuring the volume of fluid in the peritoneal cavity
EP2063774B1 (en) Method and system for non-invasive measurement of cardiac parameters
JP5175019B2 (en) Device and method for measuring fractional bioimpedance of a subject
CA2225184C (en) Apparatus and method for analyzing body composition using a new electrode system based on bioelectrical impedance analysis
US7801598B2 (en) Device and method for the determination of dry weight by continuous measurement of resistance and calculation of circumference in a body segment using segmental bioimpedance analysis
US7228170B2 (en) Device and method for monitoring and controlling physiologic parameters of a dialysis patient using segmental bioimpedance
Kanai et al. Electrical measurement of fluid distribution in legs and arms
KR101091271B1 (en) Bioimpedance methods and apparatus
EP2515755B1 (en) Analysing impedance measurements
EP1982649A1 (en) A method and device for measuring tissue oedema
EP0441777A4 (en) Noninvasive continuous mean arterial blood pressure monitor
CN106470604B (en) Acquisition device for electrical impedance analysis
Schlebusch et al. On the road to a textile integrated bioimpedance early warning system for lung edema
Patterson et al. Measurement of body fluid volume change using multisite impedance measurements
CA2386466C (en) Methods and apparatus for measuring the volume of fluid in the peritoneal cavity
Lingwood et al. Biomedical applications of electrical impedance analysis
Jindal et al. Corrected formula for estimating peripheral blood flow by impedance plethysmography
RU2094013C1 (en) Method of regional bioimpedometry and device intended for its realization
JP4664161B2 (en) Optimal electrode position searching method and apparatus for measuring visceral fat and subcutaneous fat of trunk
EP1809354B1 (en) Device and method for the determination of dry weight by continuous measurement of resistance and calculation of circumference in a body segment using segmental bioimpedance analysis
WO1998053737A1 (en) Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body
Weyer et al. Evaluation of bioimpedance spectroscopy for the monitoring of the fluid status in an animal model
Zhu et al. Estimation of volume of fluid in the peritoneal cavity by bioimpedance analysis
JPH02154741A (en) Kidney function inspecting apparatus

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12